Forschungsprojekte
Ergebnisse pro Seite:
10
2015 - 2018
Lampalizumab GX29185: A PHASE III, MULTICENTER, RANDOMIZED, DOUBLE-MASKED, SHAM-CONTROLLED STUDY TO ASSESS THE EFFICACY AND SAFETY OF LAMPALIZUMAB ADMINISTERED INTRAVITREALLY TO PATIENTS WITH GEOGRAPHIC ATROPHY SECONDARY TO AGE-RELATED MACULAR DEGENERATION- Dr. KatharinaBell,
- PD Dr. KatrinLorenz
2015 - 2016
IRISS: AN OPEN LABEL, REGISTRY STUDY OF THE SAFETY OF ILUVIEN® 190 MICROGRAMS INTRAVITREAL IMPLANT IN APPLICATOR- Prof. Dr. NorbertPfeiffer
2015 - 2017
AQUA 17850: Open-label Phase-4 study to examine the change of vision-related quality of life in subjects with diabetic macular edema (DME) during treatment with intravitreal injections of 2 mg aflibercept according to EU label for the first year of treatment- Dr. KatharinaBell,
- PD Dr. KatrinLorenz
2015 - 2017
Molecular biomarkers in experimental glaucoma and their functional relevance for apoptotic and regeneration-related signaling pathways- PD Dr. VerenaProkosch-Willing